Fenglong Xie, PhD

Illumination Health, Hoover, AL, USA

Poster(s):

• (004) Clinical and Economic Burden of Polymyalgia Rheumatica in Patients with an Inadequate Response to Glucocorticoids or Glucocorticoids Taper in a Real-World Setting
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (021) Line of Therapy of Biologics and JAK Inhibitors in RA, PsA, and AxSpA: Implications for Design and Uptake of New Drugs and Diagnostics
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (025) Overall survival in immune checkpoint inhibitor-treated patients with rheumatoid arthritis and non-small cell lung cancer: a Medicare claims study
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (041) Use of Digital Health Tools to Evaluate Change in Clinical and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis Initiating Treatment with a JAKi or TNFi
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (042) Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (149) Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (182) Factors associated with Remote Recruiting in Patient Centered Outcomes Research Studies
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (187) Will Patients engage with Digiatl Technologies as part of Routine Healthcare?
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (ASPOT13) Patient Engagement and Adherence to Digital Tasks: WEARable Activity Tracker Study Exploring Rheumatoid Arthritis Patients’ Disease Activity using Patient-Reported Outcome Measures, Clinical Measures, and Biometric Sensor Data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST